Axsome Therapeutics (AXSM) Cash from Investing Activities Growth (1y) (2016 - 2026)
Axsome Therapeutics (AXSM) Cash from Investing Activities Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Axsome Therapeutics |
12.84 Bn |
12.54 Bn |
176.48 Mn |
64.20% |
| Date | Value |
|---|
| Mar 31, 2026 |
64.20% |
| Dec 31, 2025 |
-136.67% |
| Sep 30, 2025 |
35.56% |
| Jun 30, 2025 |
75.00% |
| Mar 31, 2025 |
-244.90% |
| Dec 31, 2024 |
-328.57% |
| Sep 30, 2024 |
75.74% |
| Jun 30, 2024 |
60.90% |
| Mar 31, 2024 |
-38.03% |
| Dec 31, 2023 |
96.13% |
| Sep 30, 2023 |
-462.12% |
| Jun 30, 2023 |
99.75% |
| Mar 31, 2023 |
66.82% |
| Dec 31, 2022 |
-40,033.04% |
| Sep 30, 2022 |
74.49% |
| Jun 30, 2022 |
-281,941.64% |
| Mar 31, 2022 |
-613.45% |
| Dec 31, 2021 |
97.78% |
| Sep 30, 2021 |
-1,642.52% |
| Jun 30, 2021 |
-1,221.92% |
